Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Palmitoyltransferase ZDHHC1 (ZDHHC1) is a human enzyme belonging to the DHHC-type protein acyltransferase family, characterized by a zinc finger DHHC (Asp-His-His-Cys) motif. It catalyzes the reversible S-palmitoylation of a variety of protein substrates, which is a key lipid modification that modulates protein membrane localization, trafficking, stability, and function. ZDHHC1 plays important biological roles in the regulation of antiviral innate immune responses by mediating immune sensor activation as well as in cell growth and tumorigenesis, acting as a potential tumor suppressor in colorectal cancer. It is primarily localized in the Golgi apparatus and endoplasmic reticulum membranes. Downregulation of ZDHHC1 has been linked to unfavorable prognosis in cancer, and genetic defects have been associated with immunodeficiency disorders.
Enzymatic addition of palmitate (fatty acid) to selected cysteine residues on substrate proteins, regulating their membrane association and activity. Non-catalytic regulation of immune pathways (e.g., promoting STING1 oligomerization and downstream antiviral signaling).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Palmitoyltransferase ZDHHC1 (ZDHHC1).